Insulin resistance and diabetes are related but distinct conditions. Insulin resistance is a state where your cells stop responding properly to insulin, forcing your pancreas to produce more of it to keep blood sugar in check. Diabetes, specifically type 2 diabetes, is what happens when that compensation fails and blood sugar rises beyond normal levels. Think of insulin resistance as the engine struggling, and diabetes as the engine breaking down.
More than 115 million American adults have prediabetes, the intermediate stage between insulin resistance and full diabetes, and 8 in 10 of them don’t know it. Understanding where one condition ends and the next begins can help you recognize what’s happening in your own body.
What Insulin Resistance Actually Is
Insulin is the hormone that tells your cells to absorb sugar from your bloodstream. In insulin resistance, your muscle, fat, and liver cells stop responding to that signal efficiently. The mechanism involves glucose transporters, proteins that physically move sugar from outside a cell to inside it. When insulin works correctly, it triggers these transporters to rise to the cell surface and pull sugar in. In insulin resistance, that process is impaired, so sugar stays in the bloodstream longer than it should.
Your pancreas detects the rising blood sugar and responds by pumping out more insulin. This creates a condition called hyperinsulinemia, where insulin levels in your blood are abnormally high. For a while, this brute-force approach works. Your blood sugar stays in the normal range, but only because your pancreas is working overtime. At this stage, a standard blood sugar test might come back completely normal, which is why insulin resistance often goes undetected.
The physical signs can be subtle. One of the more visible ones is acanthosis nigricans: patches of dark, thick, velvety skin that typically show up on the neck, armpits, or groin. These patches may be itchy or develop skin tags. People with acanthosis nigricans are significantly more likely to develop type 2 diabetes later on.
How Insulin Resistance Progresses to Diabetes
The progression from insulin resistance to type 2 diabetes follows a predictable three-stage pattern. The first stage is susceptibility, shaped by genetics, conditions during fetal development, and nutrition in early childhood. These factors influence how many insulin-producing cells (beta cells) your pancreas has to work with before you even reach adulthood.
The second stage is adaptation. When insulin resistance develops, your beta cells compensate by expanding in number and increasing insulin output. The majority of people with obesity develop insulin resistance, but most of them stay in this adaptation phase indefinitely. Their blood sugar remains normal because their pancreas keeps up with the extra demand.
The third stage is beta cell failure, and this is where diabetes begins. In some people, the pancreas simply can’t keep compensating. Chronically elevated blood sugar and the metabolic stress of obesity start damaging the beta cells themselves, leading to a progressive loss of function. The cells may even revert to a less specialized state, losing their ability to produce insulin altogether. Once this happens, blood sugar rises into the diabetic range and stays there.
What separates someone who stays insulin resistant from someone who develops diabetes is largely how well their beta cells hold up under pressure. Two people with the same degree of insulin resistance can have very different outcomes based on their pancreatic reserve.
The Numbers That Define Each Stage
Doctors use a few straightforward blood tests to distinguish between normal blood sugar, prediabetes, and diabetes. The thresholds, set by the American Diabetes Association, are:
- A1C (a three-month average of blood sugar): Normal is below 5.7%. Prediabetes falls between 5.7% and 6.4%. Diabetes is 6.5% or higher.
- Fasting blood sugar: Normal is below 100 mg/dL. Prediabetes is 100 to 125 mg/dL. Diabetes is 126 mg/dL or higher.
- Oral glucose tolerance test (blood sugar two hours after drinking a sugary solution): Normal is below 140 mg/dL. Prediabetes is 140 to 199 mg/dL. Diabetes is 200 mg/dL or higher.
Insulin resistance itself doesn’t have a single universally agreed-upon cutoff. Researchers use a calculation called HOMA-IR, which combines fasting insulin and fasting glucose levels. Suggested thresholds range from as low as 2.1 to as high as 3.8 depending on the population studied. This test isn’t part of routine screening in most clinics, which is one reason insulin resistance is so often missed. Your blood sugar can look fine while your insulin levels are already elevated.
Where Prediabetes Fits In
Prediabetes is the clinical label for the gray zone between insulin resistance with normal blood sugar and full-blown diabetes. It means your blood sugar is higher than normal but hasn’t crossed the diabetes threshold yet. Prediabetes is essentially the point where your beta cells are starting to lose the battle but haven’t failed completely.
Not everyone with insulin resistance has prediabetes. You can be insulin resistant for years with perfectly normal blood sugar readings because your pancreas is still compensating. Prediabetes only shows up on tests once that compensation starts to slip. This is why it’s considered a more advanced warning sign and a stronger predictor of future diabetes.
Type 1 Diabetes Is a Different Story
Everything above applies to type 2 diabetes, which accounts for roughly 90% to 95% of all diabetes cases. Type 1 diabetes has nothing to do with insulin resistance. It’s an autoimmune condition where the immune system destroys the beta cells in the pancreas, leaving the body unable to produce insulin at all. Type 1 typically appears in childhood or adolescence and requires insulin from day one. There is no insulin resistance phase, no prediabetes stage, and no lifestyle intervention that prevents it.
Insulin Resistance Can Be Reversed
One of the most important differences between insulin resistance and diabetes is reversibility. Insulin resistance, and even prediabetes, responds well to lifestyle changes. The landmark Diabetes Prevention Program trial showed that modest weight loss combined with regular physical activity reduced the risk of developing type 2 diabetes by 58% over three years. A follow-up study found that protective effect persisted 22 years later, with a 25% reduced risk still measurable in the lifestyle intervention group compared to those who received no treatment.
The key changes in that study were losing 5% to 7% of body weight and getting about 150 minutes of moderate physical activity per week, roughly 30 minutes a day, five days a week. These aren’t extreme targets. Walking counts. The study also tested a common blood sugar medication, which reduced risk by 31% at three years and 18% at 22 years, effective but less so than lifestyle changes alone.
Once type 2 diabetes is established, it becomes harder to reverse. Some people can achieve remission through significant weight loss, particularly in the earlier years after diagnosis, but beta cell damage accumulates over time. The further along the disease has progressed, the less likely full remission becomes. This is why catching insulin resistance early matters so much: the window for reversal is widest before diabetes develops.

